BamSEC and AlphaSense Join Forces
Learn More

Q/C Technologies Inc. – Articles of Incorporation

NASDAQ: QCLS    
Share price (5/22/26): $4.18    
Market cap (5/22/26): $32.8 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Designations of Series H Convertible Preferred Stock of Q/C Technologies, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Tnf Pharmaceuticals, Inc
12/34/56
EX-3.4
from 8-K 13 pages TNF Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series I Convertible Preferred Stock
12/34/56
EX-3.3
from 8-K 51 pages Amended and Restated Certificate of Designations of Series F-1 Convertible Preferred Stock of TNF Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 50 pages Second Amended and Restated Certificate of Designations of Series F Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 38 pages Certificate of Designations of Series H Convertible Preferred Stock of TNF Pharmaceuticals, Inc
12/34/56
EX-3.4
from 8-K ~5 pages Certificate of Amendment of Certificate of Incorporation of TNF Pharmaceuticals, Inc
12/34/56
EX-3.3
from 8-K 39 pages Amended and Restated Certificate of Designations of Series F-1 Convertible Preferred Stock of TNF Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 55 pages Second Amended and Restated Certificate of Designations of Series F Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 36 pages Certificate of Designations of Series H Convertible Preferred Stock of TNF Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-Q 2 pages Certificate of Amendment of Certificate of Designations of Series F Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 10-Q 2 pages Certificate of Amendment of Certificate of Designations of Series F-1 Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of TNF Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages First Amendment to the Bylaws of TNF Pharmaceuticals, Inc
12/34/56
EX-3.6_1
from 10-K 2 pages Certificate of Amendment of Certificate of Designations of Series F-1 Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.5_3
from 10-K 2 pages Certificate of Amendment of Certificate of Designations of Series F Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Designations of Series G Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Tnf Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56